Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

The effect of rituximab on vaccine responses in patients with immune thrombocytopenia.

Nazi I, Kelton JG, Larché M, Snider DP, Heddle NM, Crowther MA, Cook RJ, Tinmouth AT, Mangel J, Arnold DM.

Blood. 2013 Sep 12;122(11):1946-53. doi: 10.1182/blood-2013-04-494096. Epub 2013 Jul 12.

2.

Better response with conjugate vaccine than with polysaccaride vaccine 12 months after rituximab treatment in lymphoma patients.

Svensson M, Dahlin U, Kimby E.

Br J Haematol. 2012 Feb;156(3):407-9. doi: 10.1111/j.1365-2141.2011.08867.x. Epub 2011 Sep 19. No abstract available.

PMID:
21923649
3.

Safety and antibody persistence following Haemophilus influenzae type b conjugate or pneumococcal polysaccharide vaccines given before pregnancy in women of childbearing age and their infants.

Santosham M, Englund JA, McInnes P, Croll J, Thompson CM, Croll L, Glezen WP, Siber GR.

Pediatr Infect Dis J. 2001 Oct;20(10):931-40.

PMID:
11642626
4.

Immunization responses in rheumatoid arthritis patients treated with rituximab: results from a controlled clinical trial.

Bingham CO 3rd, Looney RJ, Deodhar A, Halsey N, Greenwald M, Codding C, Trzaskoma B, Martin F, Agarwal S, Kelman A.

Arthritis Rheum. 2010 Jan;62(1):64-74. doi: 10.1002/art.25034.

6.

Haemophilus influenzae type b immunization in infants in the United Kingdom: effects of diphtheria/tetanus/acellular pertussis/Hib combination vaccine, significant prematurity, and a fourth dose.

Berrington JE, Cant AJ, Matthews JN, O'Keeffe M, Spickett GP, Fenton AC.

Pediatrics. 2006 Apr;117(4):e717-24. Epub 2006 Mar 20.

PMID:
16549502
7.

Immunological effect of administration of sequential doses of Haemophilus influenzae type b and pneumococcal conjugate vaccines in the same versus alternating limbs in the routine infant immunisation schedule: an open-label randomised controlled trial.

Iro MA, Khatami A, Marshall AS, Pace D, Voysey M, McKenna J, Campbell D, Attard-Montalto S, Finn A, White C, Faust SN, Kent A, Heath PT, MacLeod E, Stanford E, Findlow H, Almond R, Bai X, Borrow R, Snape MD, Pollard AJ.

Lancet Infect Dis. 2015 Feb;15(2):172-80. doi: 10.1016/S1473-3099(14)71057-6. Epub 2015 Jan 8.

PMID:
25577661
8.

Haemophilus influenzae type b vaccine failure in children is associated with inadequate production of high-quality antibody.

Lee YC, Kelly DF, Yu LM, Slack MP, Booy R, Heath PT, Siegrist CA, Moxon RE, Pollard AJ.

Clin Infect Dis. 2008 Jan 15;46(2):186-92. doi: 10.1086/524668.

PMID:
18171249
9.

Combined Haemophilus Influenzae type B-Neisseria meningitidis serogroup C vaccine is immunogenic and well tolerated in preterm infants when coadministered with other routinely recommended vaccines.

Omeñaca F, Arístegui J, Tejedor JC, Moreno-Perez D, Ruiz-Contreras J, Merino JM, Muro Brussi M, Sánchez-Tamayo T, Castro Fernandez J, Cabanillas L, Peddiraju K, Mesaros N, Miller JM.

Pediatr Infect Dis J. 2011 Nov;30(11):e216-24. doi: 10.1097/INF.0b013e3182293a82.

PMID:
21747321
10.

Safety and immunogenicity of haemophilus influenzae type B polysaccharide or conjugate vaccines in an elderly adult population.

Lottenbach KR, Granoff DM, Barenkamp SJ, Powers DC, Kennedy D, Irby-Moore S, Homan SM, Mink CM.

J Am Geriatr Soc. 2004 Nov;52(11):1883-7.

PMID:
15507066
11.

Vaccination responses and lymphocyte subsets after autologous stem cell transplantation.

van der Velden AM, Claessen AM, van Velzen-Blad H, de Groot MR, Kramer MH, Biesma DH, Rijkers GT.

Vaccine. 2007 Dec 12;25(51):8512-7. Epub 2007 Oct 25.

PMID:
17996989
12.

Evaluation of safety and efficacy as an adjuvant for the chitosan-based vaccine delivery vehicle ViscoGel in a single-blind randomised Phase I/IIa clinical trial.

Neimert-Andersson T, Binnmyr J, Enoksson M, Langebäck J, Zettergren L, Hällgren AC, Franzén H, Lind Enoksson S, Lafolie P, Lindberg A, Al-Tawil N, Andersson M, Singer P, Grönlund H, Gafvelin G.

Vaccine. 2014 Oct 14;32(45):5967-74. doi: 10.1016/j.vaccine.2014.08.057. Epub 2014 Sep 16.

PMID:
25218298
13.

Antibody repertoires in infants and adults: effects of T-independent and T-dependent immunizations.

Adderson EE.

Springer Semin Immunopathol. 2001 Dec;23(4):387-403. Review.

PMID:
11826616
14.

A randomized, controlled, blinded study of the safety and immunogenicity of Haemophilus influenzae type b conjugate vaccine injected at different intramuscular sites in Chinese infants.

Shi N, Luo F, Li L, Zheng D, Zhang Z, Wang Z, Yang L, Liu Z, Ai X, Bai Y, Lu Q.

Hum Vaccin Immunother. 2013 Nov;9(11):2311-5. Epub 2013 Jul 10.

15.

Elevated levels of maternal anti-tetanus toxin antibodies do not suppress the immune response to a Haemophilus influenzae type b polyribosylphosphate-tetanus toxoid conjugate vaccine.

Panpitpat C, Thisyakorn U, Chotpitayasunondh T, Fürer E, Que JU, Hasler T, Cryz SJ Jr.

Bull World Health Organ. 2000;78(3):364-71.

16.

The development of a new heptavalent diphtheria-tetanus-whole cell pertussis-hepatitis B-Haemophilus influenzae type b-Neisseria meningitidis serogroups A and C vaccine: a randomized dose-ranging trial of the conjugate vaccine components.

Gatchalian S, Palestroque E, De Vleeschauwer I, Han HH, Poolman J, Schuerman L, Dobbelaere K, Boutriau D.

Int J Infect Dis. 2008 May;12(3):278-88. Epub 2007 Nov 5.

18.

Immunogenicity and safety of an inactivated hepatitis A vaccine when coadministered with Diphtheria-tetanus-acellular pertussis and haemophilus influenzae type B vaccines in children 15 months of age.

Trofa AF, Klein NP, Paul IM, Michaels MG, Goessler M, Chandrasekaran V, Blatter M.

Pediatr Infect Dis J. 2011 Sep;30(9):e164-9. doi: 10.1097/INF.0b013e31821b8a7d.

PMID:
21494175
19.

Immunogenicity and safety of four different doses of Haemophilus influenzae type b-tetanus toxoid conjugated vaccine, combined with diphtheria-tetanus-pertussis vaccine (DTP-Hib), in Indonesian infants.

Punjabi NH, Richie EL, Simanjuntak CH, Harjanto SJ, Wangsasaputra F, Arjoso S, Rofiq A, Prijanto M, Julitasari, Yela U, Herzog C, Cryz SJ.

Vaccine. 2006 Mar 10;24(11):1776-85. Epub 2005 Oct 27.

PMID:
16303216
20.

Risk of invasive Haemophilus influenzae type b (Hib) disease in adults with secondary immunodeficiency in the post-Hib vaccine era.

Nix EB, Hawdon N, Gravelle S, Biman B, Brigden M, Malik S, McCready W, Ferroni G, Ulanova M.

Clin Vaccine Immunol. 2012 May;19(5):766-71. doi: 10.1128/CVI.05675-11. Epub 2012 Mar 7.

Supplemental Content

Support Center